ArticleFrontiers in oncology2022

MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.